Realfiction Holding AB (publ) (STO:REALFI)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	140	217	348	150	286	325
Market Cap Growth	-54.34%	-37.49%	132.48%	-47.73%	-11.96%	108.34%
Enterprise Value	154	224	337	125	261	319
Last Close Price	7.00	10.98	17.60	7.58	14.52	18.05
PS Ratio	8.51	11.68	17.82	7.02	15.19	22.47
PB Ratio	4.13	4.20	5.16	2.03	4.00	5.92
P/TBV Ratio	4.60	4.48	5.33	2.04	4.02	5.92
P/FCF Ratio	-	-	-	46.22	-	-
P/OCF Ratio	-	-	-	33.15	-	-
EV/Sales Ratio	9.37	12.05	17.25	5.88	13.86	22.07
EV/FCF Ratio	-	-	-	38.70	-	-
Debt / Equity Ratio	0.62	0.41	0.04	0.06	0.06	0.07
Debt / FCF Ratio	-	-	-	1.32	-	-
Asset Turnover	0.20	0.21	0.22	0.24	0.26	0.28
Inventory Turnover	1.98	1.88	0.79	1.02	1.02	0.66
Quick Ratio	0.37	0.89	2.42	4.59	9.29	8.53
Current Ratio	0.45	0.96	2.98	5.29	10.36	9.84
Return on Equity (ROE)	-41.27%	-30.88%	-8.63%	-1.91%	-1.54%	-19.71%
Return on Assets (ROA)	-13.71%	-13.31%	-5.50%	-1.14%	-3.63%	-11.44%
Return on Capital (ROIC)	-17.51%	-16.57%	-6.74%	-1.29%	-3.98%	-12.97%
Earnings Yield	-12.72%	-8.47%	-1.75%	-0.93%	-0.34%	-2.52%
FCF Yield	-	-4.40%	-0.68%	2.16%	-0.17%	-1.04%
Buyback Yield / Dilution	-0.58%	-0.16%	-0.11%	-7.50%	-16.51%	-21.77%

Updated Nov 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.